The mission of the American Foundation for AIDS Research (amfAR) is to prevent HIV infection and the disease and death associated with it and to protect the human rights of all people threatened by the epidemic of HIV/AIDS.

Because amfAR has the freedom and flexibility to respond quickly to emerging areas of scientific promise, we play a catalytic role in accelerating the pace of HIV/AIDS research and achieving real breakthroughs. amfAR-funded research has increased our understanding of HIV and has helped lay the groundwork for major advances in the study and treatment of HIV/AIDS. One of the earliest advocates for people with HIV/AIDS, we have galvanised national leadership on AIDS and were instrumental in securing key US legislation advancing access to treatment and care and strengthening research efforts.

Since being founded in 1985, we have been committed to international AIDS programmes and has supported more than 200 research projects in 39 countries outside the US. The focus of this commitment now lies in Asia, which is likely to become the next epicenter of the HIV/AIDS pandemic. A new amfAR initiative, Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia), seeks to strengthen HIV/AIDS treatment and management skills among health care professionals and to enhance health care infrastructure in preparation for the broader introduction of HIV/AIDS drugs in the region.

Funded by voluntary contributions from individuals, foundations, and corporations, we have invested over US$220 million in our mission since 1985 and have funded grants to more than 2,000 research teams worldwide.

For more information, please visit our website: www.amfar.org

and these links:

HIV/AIDS treatment and clinical trials information: www.amfar.org/gl

amfAR's initiative in Asia (TREAT Asia):
www.TREATAsia.org